Effect of Erenumab-aooe on Disability and Work Productivity in Employed Subjects With Episodic Migraine
Clinical trial NCT03912337 · TERMINATED
Trial details
- NCT number
- NCT03912337
- Sponsor
- Amgen
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-04
- Primary completion
- 2021-07-28
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.